Indeed, the demonstration that NOX4 deficiency may promote HCC in cirrhotic livers suggests that long-term, complete inhibition of NOX4 in patients with advanced cirrhosis may carry risks. The gene discussed is NOX4; the disease is hepatocellular carcinoma.